Drug Profile
JW 1521
Alternative Names: CG-1521; JW-1521Latest Information Update: 10 May 2021
Price :
$50
*
At a glance
- Originator CircaGen Pharmaceutical
- Developer San Rocco Therapeutics
- Class Antineoplastics; Hydroxamic acids; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Prostate cancer